251 related articles for article (PubMed ID: 22431065)
21. Twist1 is required for the development of UVB-induced squamous cell carcinoma.
Eguiarte-Solomon F; Blazanin N; Rho O; Carbajal S; Felsher DW; Tran PT; DiGiovanni J
Mol Carcinog; 2021 May; 60(5):342-353. PubMed ID: 33713497
[TBL] [Abstract][Full Text] [Related]
22. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
23. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
24. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
25. CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ.
Gunderson AJ; Mohammed J; Horvath FJ; Podolsky MA; Anderson CR; Glick AB
J Invest Dermatol; 2013 Apr; 133(4):955-63. PubMed ID: 23151849
[TBL] [Abstract][Full Text] [Related]
26. The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation.
Byrne SN; Beaugie C; O'Sullivan C; Leighton S; Halliday GM
Am J Pathol; 2011 Jul; 179(1):211-22. PubMed ID: 21703403
[TBL] [Abstract][Full Text] [Related]
27. Does imiquimod pretreatment optimize 308-nm excimer laser (UVB) therapy in psoriasis patients?
Tacastacas JD; Oyetakin-White P; Soler DC; Young A; Groft S; Honda K; Cooper KD; McCormick TS
Photodermatol Photoimmunol Photomed; 2017 Jul; 33(4):193-202. PubMed ID: 28168735
[TBL] [Abstract][Full Text] [Related]
28. Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation.
Jiang Y; Wang W; Zheng X; Jin H
J Immunol Res; 2020; 2020():5980190. PubMed ID: 32280718
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
30. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
[TBL] [Abstract][Full Text] [Related]
31. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
[TBL] [Abstract][Full Text] [Related]
32. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
33. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
[TBL] [Abstract][Full Text] [Related]
34. Keratinocytes costimulate naive human T cells via CD2: a potential target to prevent the development of proinflammatory Th1 cells in the skin.
Orlik C; Deibel D; Küblbeck J; Balta E; Ganskih S; Habicht J; Niesler B; Schröder-Braunstein J; Schäkel K; Wabnitz G; Samstag Y
Cell Mol Immunol; 2020 Apr; 17(4):380-394. PubMed ID: 31324882
[TBL] [Abstract][Full Text] [Related]
35. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
[TBL] [Abstract][Full Text] [Related]
36. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.
Ito H; Ando T; Arioka Y; Saito K; Seishima M
Immunology; 2015 Apr; 144(4):621-30. PubMed ID: 25322876
[TBL] [Abstract][Full Text] [Related]
38. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
39. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
40. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model.
Lee M; Kim SH; Kim TG; Park J; Lee JW; Lee MG
J Dermatol Sci; 2018 Jul; 91(1):52-59. PubMed ID: 29655588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
